Biocomposites expands its product portfolio with the launch of SYNICEM™ spacers within the UK
- SYNICTM hip, knee and shoulder spacers are preformed and loaded with gentamicin to keep up house and assist therapy of an infection.
- Already efficiently utilized in UK sufferers as a part of their an infection therapy methods
KEELE, England, Nov. 21, 2023 /PRNewswire/ — Biocomposites, a global medical gadgets firm that engineers, manufactures and markets world main merchandise to be used in an infection administration in bone and comfortable tissue, is happy to announce the launch of SYNICEMTM hip, knee and shoulder preformed spacers within the United Kingdomand their profitable use in sufferers present process joint surgical procedure.
SYNICTM spacers are antibiotic-loaded, preformed spacers which overcome the challenges of conventional intra-operative moulded and handmade spacers. They assist help surgeons’ revisions of the hip, knee and shoulder by preserving articular house and aiding the therapy of an infection. Precision engineered for consistency and structural uniformity, SYNICEMTM spacers present a excessive native focus of gentamicin and supply case-by-case flexibility to avoid wasting surgeons’ time throughout their procedures.
The launch of SYNICEMTM spacers within the UK follows Biocomposites’ acquisition of French-based medical system producer, Synimed, in 2022. Synimed specialises in bone cement and polymer associated merchandise utilizing in-house proprietary core polymer manufacturing and formulation.
Rohit DhawanGuide Orthopaedic Surgeon, Royal United Hospitals Bathtub NHS Basis Belief, commented: “Biocomposites’ SYNICEM spacers are actually helpful for orthopaedic surgeons who take care of infections. Prepared to make use of and out there in quite a lot of sizes to suit totally different affected person anatomies, they supply the flexibleness to allow a swift process, leaving sufferers infection-free and capable of resume their day-to-day actions. I’m delighted that they are going to now be available within the UK.”
Michael HarrisChief Govt Officer of Biocomposites, mentioned: “I am delighted that our acquisition of Synimed has enriched our portfolio of merchandise that help surgeon’s managing and treating an infection. SYNICEM spacers already assist many sufferers all through the world and bringing them into the UK and wider Biocomposites community will be certain that extra sufferers profit.”
Biocomposites is a global medical gadgets firm that engineers, manufactures, and markets world main merchandise to be used in an infection administration in bone and comfortable tissue. Primarily based in Keele, UK, it has international operations throughout Europe, USA, Argentina, Canada, Chinaand India. Biocomposites is a world chief within the improvement of revolutionary calcium compounds and bone cements for surgical use. Its merchandise regenerate bone and goal an infection dangers throughout quite a lot of specialties, together with musculoskeletal an infection, orthopaedics, trauma, backbone, foot and ankle, podiatry, and sports activities accidents. Biocomposites merchandise at the moment are utilized in over a million procedures each year and offered in additional than 100 nations all over the world. Please go to biocomposites.com to study extra.